Budget Outcome for Pathology Providers Broadly in Line With Our Expectations; Industry Undervalued
Top pathology providers remain significantly undervalued following the supportive pathology policy changes announced in the federal budget.
Top pathology providers remain significantly undervalued following the supportive pathology policy changes announced in the federal budget.
Sonic has a leading market position in most of its geographies and as a result benefits from a cost advantage derived from scale.
Elevated covid-19 testing is not able to be maintained and acquisitive growth is becoming more expensive to achieve.
Metric
|
SHL
|
HLS
|
DGX
|
---|---|---|---|
Price/Earnings (Normalized) | 24.68 | 2.48 | 15.98 |
Price/Book Value | 1.65 | 0.87 | 2.40 |
Price/Sales | 1.51 | 0.45 | 1.69 |
Price/Cash Flow | 11.09 | 2.68 | 11.12 |
Metric
|
SHL
|
HLS
|
DGX
|
---|---|---|---|
Quick Ratio | 0.78 | 0.44 | 0.78 |
Current Ratio | 0.94 | 0.53 | 0.97 |
Interest Coverage | 5.95 | −13.26 | 7.31 |
Metric
|
SHL
|
HLS
|
DGX
|
---|---|---|---|
Return on Assets (Normalized) | 4.07% | 0.10% | 7.33% |
Return on Equity (Normalized) | 7.01% | 0.23% | 15.76% |
Return on Invested Capital (Normalized) | 4.52% | 2.27% | 9.73% |
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Ybqwqbmp | Knjg | $227.2 Bil | |
DHR
| Danaher Corp | Ywrytqbnxq | Kfrgmf | $196.9 Bil | |
A
| Agilent Technologies Inc | Qdbkrlwz | Xwdz | $45.2 Bil | |
IDXX
| IDEXX Laboratories Inc | Jbydtjdnq | Wfxsg | $44.9 Bil | |
IQV
| IQVIA Holdings Inc | Fbxrwzlqw | Fkhkggw | $42.8 Bil | |
MTD
| Mettler-Toledo International Inc | Jjnybqrgg | Szqyr | $32.5 Bil | |
ICLR
| Icon PLC | Fbnffdhzz | Xsqsnh | $26.0 Bil | |
WAT
| Waters Corp | Rxxfhggnm | Pcz | $21.1 Bil | |
LH
| Laboratory Corp of America Holdings | Sprtstktx | Mxrncl | $17.8 Bil | |
ILMN
| Illumina Inc | Sbpmrdqr | Dcvxjrp | $17.7 Bil |